WORLD MALARIA DAY - CDC 2ab.jpg
WORLD MALARIA DAY 3ab.jpg

World Malaria Day

A p r i l   2 5 ,  2 0 2 2

WORLD MALARIA DAY 2ab.jpg

World Health Organization: 

Harness innovation to reduce the malaria disease burden and save lives!

WHO DR. TEDROS 5ab.jpg

“This is a historic moment,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, “The long-awaited malaria vaccine for children is a breakthrough for science, child health, and malaria control.”

The RTS,S vaccine is the product of 30 years of research and development by British drugmaker GlaxoSmithKline (GSK) in search of a vaccine that would help eradicate malaria disease that causes the death of more than 260,000 children under the age of five annually in Africa.

WHO - Learn more on the following web page:

WORLD MALARIA DAY - CDC 2ab.jpg
WORLD MALARIA DAY 3ab.jpg

QUESTION?

Has "Zero Malaria" been

reached . . .

Malaria In Babies.jpg

Globally???

WOLRD MALARIA DAY 4ab.png
WORLD MALARIA DAY 5ab.jpg

NOT YET!

TIME TO LEARN MORE:

What is . . . Malaria?

Image Courtesy, Wikipedia - Mikael Häggström

Following Definition Courtesy, Wikipedia The Free Encyclopedia

Malaria is a mosquito-borne infectious disease of [which affects] humans and other animals caused by protists (a type of microorganism) of the genus Plasmodium. The protists first infect the liver, then act as parasites within red blood cells, causing symptoms that typically include fever and headache, in severe cases progressing to coma or death. The disease is widespread in tropical and subtropical regions in a broad band around the equator, including much of Sub-Saharan Africa, Asia, and the Americas.

 

Five species of Plasmodium can infect and be transmitted by humans. Severe malaria is largely caused by P. falciparum while the disease caused by P. vivax, P. ovale, and P. malariae is generally a milder form that is rarely fatal. The zoonotic species P. knowlesi, prevalent in Southeast Asia, causes malaria in macaques but can also cause severe infections in humans. Malaria is prevalent in tropical regions because the significant amounts of rainfall, consistently high temperatures and high humidity, along with stagnant waters in which mosquito larvae readily mature, provide them with the environment they need for continuous breeding. Disease transmission can be reduced by preventing mosquito bites by distribution of mosquito nets and insect repellents, or with mosquito-control measures such as spraying insecticides and draining standing water.

The World Health Organization has estimated that in 2010, there were 216 million documented cases of malaria. Around 655,000 people died from the disease, many of whom were children under the age of five.[1] The actual number of deaths may be significantly higher, as precise statistics are unavailable in many rural areas, and many cases are undocumented. P. falciparum — responsible for the most severe form of malaria — causes the vast majority of deaths associated with the disease. Malaria is commonly associated with poverty, and can indeed be a cause of poverty and a major hindrance to economic development.

 

Despite a clear need, no vaccine offering a high level of protection currently exists. Efforts to develop one are ongoing. Several medications are available to prevent malaria in travelers to malaria-endemic countries (prophylaxis). A variety of antimalarial medications are available. Severe malaria is treated with intravenous or intramuscularquinine or, since the mid-2000s, the artemisinin derivative artesunate, which is superior to quinine in both children and adults and is given in combination with a second anti-malarial such as mefloquine. Resistance has developed to several antimalarial drugs, most notably chloroquine and artemisinin.

Learn more about Malaria on the following web page:

Learn more about Malaria on the following web page:

Learn more about Malaria on the following web page:

Special Announcement

 Keep the Date:  Monday, 25 April 2022  VIRTUAL via Zoom

Keynote Speaker - Dr. Matshidiso Rebecca Moeti, Regional Director for Africa, WHO:

“Science, research and precision disease control with malaria as entry point”

Dr. Matshidiso Rebecca Moeti, Regional Director for Africa 1ab.jfif

This year's World Malaria Day symposium "Malaria in Africa: Translating Science into Practice" will feature presentations by the five NIH International Centers of Excellence for Malaria Research (ICEMRs) that are actively working in Africa (Mali, Uganda, Ethiopia, Kenya, Malawi, Mozambique, Democratic Republic of Congo, Zimbabwe, and Zambia).

WORLD MALARIA DAY 2022 JOHN HOPKINS SYMPOSIUM.png

Courtesy,

john hopkins bloomberg school of public health logo.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

CONTINUING

TO AIM FOR . . .

ZERO MALARIA!

WORLD MALARIA DAY 7ab.jpg
WORLD MALARIA DAY 6ab.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Learn more about . . .

World Malaria Day

on the following WHO web page:

WORLD MALARIA DAY 4ab.jpg

Courtesy, WHO

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

The World must continue

the work toward . . .

"ZERO MALARIA!"

WORLD MALARIA DAY 8ab.jpg

More than nets are needed:

an effective vaccine for

Humanity's victims of

Malaria is . . .

FINALLY  DEVELOPED FOR BENEFICIAL

USAGE!

- EPACHA Foundation -

 

 

EPACHA Foundation Extends

Sincere Thanks to

UNITED NATIONS

A n d

for allowing use of images, visuals and

print presented herein.

--

--

If you’ve missed the work of EPACHA in its Phase I duration, please be encouraged to click on the below web links.

Sincerest Thanks are Extended to http://archive.org/web/ for having made possible an archived viewing of

 

EPACHA Foundation’s entire volume of its Phase I web pages: